Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Treasury Shares (2021 - 2025)

Barinthus Biotherapeutics' Treasury Shares history spans 2 years, with the latest figure at $864724.0 for Q4 2025.

  • For Q4 2025, Treasury Shares changed N/A year-over-year to $864724.0; the TTM value through Dec 2025 reached $864724.0, changed N/A, while the annual FY2025 figure was $864724.0, N/A changed from the prior year.
  • Treasury Shares reached $864724.0 in Q4 2025 per BRNS's latest filing, up from $264042.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $864724.0 in Q4 2025 to a low of $264042.0 in Q1 2021.